4INOMATA T,OGAWA Y,NISHIOKA A,et al.The immunopotenti-ation effects of the bifunctional radiosensitizer KIN-806 in corn-parison with its analogs KIN-8O4 anti KIN-844[J].Oncol Rep,1999,6(6):1209-1221.
5MARCUS K J,DUTTON S C,BARNES P,et al.A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma[J].Int J Radiat Oncol Biol Phys,2003,55(5):1182-1185.
6ULLAL S D,SHENOY K K,PAI M R,et al.Safety and radio-sensitizing efficacy of sanazole (AK 2123) in oropharyngeal cancers:randomized controlled double blind clinical trial[J].Indian J Cancer,2006,43(4):151-155.
8PETERS K B,WANG H,BROWN J M,et al.Inhibition of DNA replication by tirapazamine[J].Cancer Res,2001,61(14):5425-5431.
9KINSELLA T J,KINSELLA M T,SEO Y,et al.5-iodo-2-pyri-midinone-2'-deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts[J].Int J Radiat Oncol Biol Phys,2007,69(4):1254-1261.
10KINSELLA T J,KINSELLA M T,HONG S,et al.Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats:impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization[J].Cancer Chemother Pharmacol,2008,61(2):323-334.
7Yi JL,Gao L,Huang XD,et al.Nasopharyngeal carcinoma treated by radical radiothempy alone:ten year experience of a single institution[J].Int J Radiat Oncol Biol Phys,2006,65(1):161.
8Lee AWM,Sze WM,Au JS,et al.Treatment results for nasopharyngeal carcinoma in the modern era:the Hong Kong experience[J].Int J Radiat Oncol Bilo Phys,2005,61(4):1107.
9Chua DT,Sham JS,Au GK.A phase study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy[J].Oral Oncol,2003,39(4):361.
10Sarhan S,Kayisogullari U,Ercan I,et al.Randomized phase 2 study of radiotherapy alone versus radiotherapy with paclitaxel in non-small cell lung cancer[J].J Int Med Res,2004,32(4):375.
